iBio Inc. | Income Statement
Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,007.00
205.00
1,851.00
948.00
394.00
444
SG&A Expense
7,336.00
5,425.00
8,106.00
9,868.00
12,992.00
12,962
EBIT
6,667.00
5,581.00
6,618.00
9,860.00
14,274.00
14,227
Unusual Expense
520.00
1,863.00
-
-
-
-
Non Operating Income/Expense
60.00
44.00
16.00
12.00
25.00
19
Interest Expense
-
-
-
807.00
1,929.00
1,915
Pretax Income
6,198.00
3,666.00
6,625.00
10,657.00
16,139.00
16,108
Consolidated Net Income
6,198.00
3,666.00
6,625.00
10,657.00
16,139.00
16,108
Net Income
6,198.00
3,666.00
6,625.00
9,764.00
14,532.00
16,105
Net Income After Extraordinaries
6,198.00
3,666.00
6,625.00
9,764.00
14,532.00
16,105
Net Income Available to Common
6,198.00
3,666.00
6,625.00
9,764.00
14,622.00
16,365
EPS (Basic)
1.26
0.58
0.93
1.20
1.60
1.54
Basic Shares Outstanding
4,938.10
6,296.80
7,149.50
8,097.30
8,911.20
10,631
EPS (Diluted)
1.26
0.58
0.93
1.21
1.64
1.54
Diluted Shares Outstanding
4,938.10
6,296.80
7,149.50
8,097.30
8,911.20
10,631
EBITDA
6,329.00
5,220.00
6,255.00
8,920.00
12,598.00
12,518
Non-Operating Interest Income
9.00
8.00
9.00
22.00
39.00
15
Minority Interest Expense
-
-
-
893.00
1,607.00
3
Preferred Dividends
-
-
-
-
90.00
260
About iBio
View Profile
